Does lisinopril protect kidneys
Pro Research Analysisby 
Searched over 200M research papers
Lisinopril and Kidney Protection: A Comprehensive Review
Introduction to Lisinopril and Kidney Health
Lisinopril, an angiotensin-converting enzyme (ACE) inhibitor, is widely used to manage hypertension and heart failure. Its potential renoprotective effects, particularly in patients with diabetic nephropathy and other kidney diseases, have been the subject of extensive research. This article synthesizes findings from multiple studies to evaluate whether lisinopril protects kidney function.
Lisinopril in Diabetic Nephropathy
Blood Pressure Control and Kidney Function
Several studies have compared the effects of lisinopril with other antihypertensive agents, such as atenolol and nisoldipine, in patients with diabetic nephropathy. These studies consistently show that while both lisinopril and atenolol effectively reduce blood pressure, lisinopril has a more significant impact on reducing albuminuria, a marker of kidney damage Nielsen1997Nielsen1994Tarnow2000. For instance, one study found that lisinopril reduced albuminuria by 55%, compared to 15% with atenolol . Another study reported a 45% reduction in albuminuria with lisinopril, compared to 12% with atenolol .
Long-Term Kidney Function Preservation
In a four-year study comparing lisinopril with nisoldipine, both drugs were found to have similar long-term effects on the progression of diabetic nephropathy. However, lisinopril was more effective in reducing albuminuria initially . This suggests that while both medications can slow kidney function decline, lisinopril may offer additional benefits in the early stages of treatment.
Lisinopril in Non-Diabetic Kidney Diseases
Chronic Kidney Disease (CKD)
Lisinopril has also been studied in non-diabetic kidney diseases. In patients with mild proteinuric non-diabetic nephropathies, lisinopril was more effective than other antihypertensive agents in slowing the progression of renal insufficiency . Over a follow-up period of approximately 22.5 months, patients treated with lisinopril showed a significantly smaller decline in renal function compared to those on alternative therapies .
Adriamycin Nephropathy
In a rat model of adriamycin-induced nephropathy, lisinopril was shown to reduce proteinuria, lower systolic blood pressure, and decrease kidney damage . This study also highlighted the role of renalase, a kidney enzyme, in mediating the protective effects of lisinopril .
Combination Therapies Involving Lisinopril
ACE Inhibitors and ARBs
Combining lisinopril with angiotensin-receptor blockers (ARBs) has been explored to enhance renoprotection. However, a study on combination therapy with lisinopril and losartan in diabetic nephropathy patients was halted early due to safety concerns, including increased risks of hyperkalemia and acute kidney injury . This suggests that while combination therapy may offer some benefits, it also carries significant risks.
Lisinopril and L-Arginine
In a severe rat model of membranous nephropathy, combining lisinopril with L-arginine, a precursor of nitric oxide, showed promising results. This combination was more effective in reducing proteinuria and kidney damage than lisinopril alone, suggesting a potential therapeutic strategy for patients with severe nephropathy .
Conclusion
Lisinopril has demonstrated significant renoprotective effects in both diabetic and non-diabetic kidney diseases. It effectively reduces albuminuria and slows the progression of kidney function decline. While combination therapies involving lisinopril may offer additional benefits, they also come with increased risks. Overall, lisinopril remains a valuable option for protecting kidney function, particularly in patients with diabetic nephropathy.
Sources and full results
Most relevant research papers on this topic
Impact of Lisinopril and Atenolol on Kidney Function in Hypertensive NIDDM Subjects With Diabetic Nephropathy
Lisinopril effectively reduces albuminuria more than atenolol in hypertensive NIDDM patients with diabetic nephropathy, potentially improving kidney function.
Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy.
Both lisinopril and nisoldipine have similar long-term renoprotective effects in hypertensive type 1 diabetic patients with diabetic nephropathy.
Effect of Lisinopril on the progression of renal insufficiency in mild proteinuric non-diabetic nephropathies.
Lisinopril has a specific renoprotective effect in addition to blood pressure control in patients with mild proteinuria, slowing the progression of non-diabetic chronic renal diseases.
DOI